微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 48.52% | 9.86% | 1.71% | 75/132 | 51.53% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 47.71% | 9.55% | 2.12% | 76/132 | 51.65% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 46.72% | 7.55% | 3.16% | 78/132 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 45.29% | -9.3% | 2.53% | 81/132 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 44.17% | -20.38% | 1.42% | 83/132 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 43.55% | -21.68% | 0.26% | 85/132 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 43.44% | -23.58% | -13% | 82/132 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 49.93% | 14.53% | -9.99% | 76/132 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 55.47% | 33.02% | -0.25% | 65/132 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 55.61% | 32.86% | -2.16% | 64/132 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 56.84% | 2% | 30.38% | 59/132 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 43.6% | 7.65% | 4.55% | 87/132 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 41.7% | 2% | -0.38% | 87/132 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 41.86% | 6.74% | 3.36% | 90/132 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 40.5% | -3.28% | 3.27% | 102/132 | 57.29% | 三友医疗 | 90.73% | 行业排名> |
| 2021-06-30 | 39.22% | 12.59% | -6.34% | 95/132 | 58.42% | 三友医疗 | 90.5% | 行业排名> |
| 2020-12-31 | 41.87% | 44.62% | 44.62% | 104/132 | 59.59% | 三友医疗 | 90.29% | 行业排名> |
| 2019-12-31 | 28.95% | -13.03% | -13.03% | 103/132 | 56.37% | 正海生物 | 90.78% | 行业排名> |
| 2018-12-31 | 33.29% | 2% | -4.42% | 92/132 | 55.53% | 正海生物 | 91.59% | 行业排名> |
| 2018-06-30 | 34.83% | 2% | 2% | 43/132 | 51.56% | 正海生物 | 92.23% | 行业排名> |